Table 5.
Biochemical results in blood before and after WBC (T1 vs. T3): hsCRP, TAS, IL-6, IL-10, and NO in experimental and CGs.
| Parameter | Group | T1 Median (Q1–Q3) Mean ± SD |
T3 Median (Q1–Q3) Mean ± SD |
Interaction description |
Linear mixed model analysis—interaction effect | ||
|---|---|---|---|---|---|---|---|
| Estimate | Sth Error | p- value | |||||
| hsCRP [mg/L] | EG | 1.090 (0.580–3.133) 2.105 ± 2.135 |
1.179 (0.605–3.442) 2.689 ± 3.115 |
(Intercept) T3 Experimental group |
2.232 0.339 −0.005 |
0.459 0.413 0.554 |
0.000 0.415 0.993 |
| CG | 1.900 (0.400–4.240) 2.387 ± 2.234 |
1.179 (0.670–3.312) 2.431 ± 2.658 |
|||||
| IL-6 [pg/ml] | EG | 0.000 (0.000–6.860) 26.955 ± 94.241 |
0.000 (0.000–8.625) 29.924 ± 111.861 |
(Intercept) T3 Experimental group |
5.532 1.570 22.122 |
14.604 1.968 21.329 |
0.707 0.429 0.305 |
| CG | 0.000 (0.000–7.107) 6.144 ± 16.940 |
0.000 (0.000–5.234) 6.491 ± 18.046 |
|||||
| IL-10 [pg/ml] | EG | 5.686 (3.732–7.130) 6.360 ± 5.390 |
5.686 (5.009–7.130) 6.951 ±4.699 |
(Intercept) T3 Experimental group |
7.518 0.874 −1.300 |
1.165 0.465 1.653 |
0.000 0.067 0.436 |
| CG | 6.535 (4.427–8.282) 7.389 ± 5.060 |
6.350 (4.487–10.562) 8.522 ± 7.184 |
|||||
| TAS [mmol/L] | EG | 1.520 (1.470–1.630) 1.537 ± 0.135 |
1.520 (1.443–1.630) 1.539 ± 0.141 |
(Intercept) T3 Experimental group |
1.501 0.020 0.027 |
0.025 0.022 0.030 |
0.000 0.366 0.377 |
| CG | 1.470 (1.410–1.600) 1.492 ± 0.127 |
1.520 (1.440–1.625) 1.531 ± 0.149 |
|||||
| NO [nM] | EG | 459.973 (283.504–676.548) 516.739 ±371.622 |
524.143 (157.169–810.905) 865.864 ±1434.050 |
(Intercept) T3 Experimental group |
2033.609 −64.892 -−129.570 |
760.832 130.334 928.640 |
0.015 0.624 0.239 |
| CG | 315.589 (143.131–2626.274) 2087.044 ±3266.396 |
652.484 (427.887–2296.242) 1915.282 ±2575.159 |
|||||
EG, experimental group; CG, control group; TAS, total antioxidant status; NO, nitric oxide; hsCRP, High sensitivity C-reactive protein; IL, Interleukin.